Global Heel Incision Devices Market By Age Group (Micro-preemie, Preemie, Newborn, Infant), By End User (Hospitals & Specialty Clinics, Ambulatory Surgical Centers, Other End-Users), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2021-2031

A heel incision device is a precise and safe medical device that is specifically designed for infants. This type of device provides an effective means of taking blood samples from the heels of preterm and newborn babies. These incision devices are used by neonatal professionals as well as caregivers. A heel incision device helps to assess and monitor the health of premature babies. In addition, they help to screen different diseases and conditions, which can be diagnosed using blood samples from newborns.

Heel incision devices use the incision method, wherein a blade makes a gentle sweeping arc in the heel above nerve fibers in order to minimize discomfort. Increasing global populations, in conjunction with surging cases of premature births, are anticipated to augment projected revenues for this market. According to the World Health Organization (WHO), an estimated 15 million babies are born premature, and premature birth complications are typically common causes of death among child under the age of five years.

In addition, as per the study by the WHO, spanning 184 countries, the rate of premature births ranges from 5% to 18% of conceived infants. These aforementioned parameters are anticipated to propel the financial trajectory of the global heel incision devices market over the forecast period. Moreover, newborn screening is a public health service carried out in the United States.

Three aspects of newborn screening that are usually performed are – blood tests, hearing screening, and pulse oximetry. Agencies in North America have made it compulsory to screen all children born in private sector hospitals. As such, an increase in awareness levels and mandatory newborn screening are elements anticipated to bolster the revenue growth of the global heel incision devices market.

Detailed Segmentation:

The global heel incision devices market is segmented on the basis of – age group, end user, and region. A detailed segmental description is listed below:

Based on Age Group

• Micro-preemie
• Preemie
• Newborn
• Infant

Based on End User

• Hospitals & Specialty Clinics
• Ambulatory Surgical Centers
• Other End-Users

Based on Key Player

• Becton
• Dickinson and Company
• Owen Mumford Ltd.
• Cardinal Health
• Smiths Medical
• Clinical Innovations LLC
• MediCore Inc.
• Vitrex Medical A/S NSP Medicals
• Torvan Medical Inc.
• among others.

Based on Region

• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

Market Dynamics

A steady surge in preterm and premature birth cases across the globe is anticipated to bolster the revenue growth of the global heel incision devices market. The high costs associated with heel incision devices, along with a lack of skilled professionals to handle these devices in developing nations are factors expected to potentially restrain economic growth opportunities for this industry to a certain extent. In addition, owing to the impacts of COVID-19, raw material supply chains that are needed to manufacture heel incision devices have been disrupted in several countries.

As such, the revenue growth of heel incision devices is expected to register a decline as the manufacturers of these medical devices have had to slow down their respective production activities. However, as these lockdowns are gradually relaxed and economies begin to recover, this market is expected to subsequently recover accordingly.

Surging awareness levels pertaining to infant care products are likely to augment projected revenues for the global heel incision devices market in the foreseeable future. Moreover, consistent growth in the GDP of both developed and developing nations has also aided in the evolution of the healthcare sector.

Owing to this aforementioned growth in GDP, particularly in that of emerging countries, prominent market players are now beginning to exhibit a keen sense of interest towards these regions, thereby complementing potential revenue expansion prospects for the global heel incision devices market in the process.

Competitive Landscape:

Certain key players operating in this global market are – Becton, Dickinson and Company, Owen Mumford Ltd., Cardinal Health, Smiths Medical, Clinical Innovations LLC, MediCore Inc., Vitrex Medical A/S NSP Medicals, and Torvan Medical Inc. among others. These aforementioned companies develop new products/services, adopt expansion strategies, and undertake partnerships, collaborations, and mergers & acquisitions to gain traction in the global heel incision devices market.

Key Developments:

• In February 2020, LABORIE Medical Technologies, a leading diagnostic and therapeutic medical technology company, acquired Clinical Innovations LLC.
• In April 2019, EveryLife Foundation for Rare Disease and Baby’s First Test co-hosted a newborn screening bootcamp in the United States. Drives such as these are anticipated to boost the demand for newborn screening tests, and the need of heel incision devices.

For the Heel Incision Devices Market research study, the following years have been considered to estimate the market size: